Rachelle Crescenzi1, Paula M.C. Donahue2,3, Vaughn G Braxton1, Allison O Scott1, and Manus J Donahue1,4,5,6
1Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, United States, 2Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, United States, 3Vanderbilt Dayani Center for Health and Wellness, Nashville, TN, United States, 4Neurology, Vanderbilt University Medical Center, Nashville, TN, United States, 5Psychiatry, Vanderbilt University Medical Center, Nashville, TN, United States, 6Physics and Astronomy, Vanderbilt University, Nashville, TN, United States
Synopsis
A lack of MRI methods exist that are designed with
sensitivity to the lymphatics, even though components of the lymphatic system
have been discovered in every major organ system of the body and likely play an
understudied role in disease. In this work we performed quantitative relaxation
time mapping in axillary lymph node substructures, the cortex and hilum, for
the first time at 3 Tesla and used these values to optimize structural imaging parameters
for the lymphatics. Knowledge of fundamental MR parameters in the lymphatics is
the first step to developing novel imaging sequences that exploit lymphatic
tissue in vivo.
Purpose
The goal of this
work is to quantify 3T MRI relaxation times in
vivo in human axillary lymphatic nodes for the first time, which will
enable the development of optimized structural and functional imaging protocols
for evaluating lymph node morphology and function in patients with breast
cancer and related co-morbidities. More specifically, metastatic lymph nodes
can become inflated with focal MR hyper/hypointensities in the cortex and may
be devoid of a hilum1. However, MRI is not used routinely for lymph
node imaging and there is a lack of knowledge of even the most fundamental MRI
parameters, e.g., T1 and T2 relaxation time, of
healthy lymph node substructures. Additionally, more novel MRI methods, such as
CEST2 and spin labeling3 are being applied for lymphatic
imaging, however the quantitative accuracy of these methods is suboptimal
without knowledge of lymph relaxation times. Here, we quantify lymphatic node
substructure relaxation times for the first time at 3T, and use this
information to recommend optimal imaging protocols for lymph node imaging using
MRI.Methods
Healthy females (n=15;
age=45±13
years; body-mass-index=28.7±7.8kg/m2) were imaged supine using a torso coil (16-channel
RX) at 3T (Philips Achieva). The axillary region was located (Figure 1A) and axillary lymph nodes
identified on transverse images acquired with the multi-point Dixon method to
produce water-only (Figure 1B) and
fat-only contrast with the following
parameters: TR=3.5ms, TE1=1.15ms, TE2=2.3ms; 3D gradient-echo;
FOV=520x424x192mm3; spatial-resolution=0.9x0.7x2.5mm3;
duration=18s). Sub-nodal structures of the cortex and hilum were visualized at
high spatial-resolution by T2-weighted
imaging with fat suppression (SPAIR) using: TR/TE=3500/60ms; FOV=180x180x50mm3; resolution=0.3x0.3x5mm3;
Figure 1C). Quantitative
relaxation time mapping was performed over a bilateral FOV (520x424x49.5mm3; slices=9, spatial-resolution=1.80x1.47x5.5mm3).
T2 mapping was achieved
using TE=9–189ms (interval=12ms), and TR=4000ms. T1 mapping was achieved using the mutli-flip angle method
(FA=20, 40, 60 degrees, TR/TE=100/4.6ms)4. Flip angle inefficiency
was corrected using a B1
map acquired by a dual-TR approach (TR1=30ms, TR2=130ms,
FA=60 degrees). Relaxation time maps and B1-efficiency
correction were calculated using custom routines in Matlab and previously published
algorithms2. Segmentation of the nodal cortex was carried out
manually (Figure 2) in 40 lymph
nodes and a discernable fatty hilum region was segmented in 34 of these nodes. Surrounding
tissue regions were segmented from the arm muscle and periscapular fat tissue. Finally,
protocols for optimal lymph node substructure contrasts were evaluated
experimentally for T1-weighted
and T2-weighted imaging.Results
Table 1
reports measured T1 and T2 values of lymphatic
structures and tissues inferior to axilla, in addition to literature values of
measured relaxation times in lymphatic fluid3 and arterial blood5-6.
Figure 3A-B reports the simulated
longitudinal signal (Mz) recovery or transverse signal (Mxy)
decay of these tissues, and Figure 3C-D
reports the difference in signal between tissues of interest, where the maximum
difference indicates the optimal TR or TE to achieve image contrast. Figure 4A shows that optimized contrast
between the cortex of a lymph node and surrounding axillary fat on a T2-SPAIR acquisition was
achieved at TR/TE=3500/121ms. Additionally a lymphatic vessel can be visualized
at TE=121ms compared to shorter or longer TEs sampled. Using a T1-weighted acquisition, the
hilum of a lymph node exhibits optimal contrast from the cortex at TR=580ms. Within
the hilum a hypointensity is discerned at TR=1328ms, in accord with TR
optimized between lymphatic fluid and hilum (Figure 4B). Visualization of lymph node substructures and efferent
vessels was achieved at high spatial resolution in vivo at 3T (Figure 5).Discussion
Based on relaxation time parameters
measured here in healthy lymphatic tissue at 3T, we propose a structural
imaging protocol which offers improved spatial resolution and identification of
lymphatic tissue including nodes and vascular architecture: T2-weighted TR/TE=3500/121ms;
and T1-weighted
TR/TE=1328/15ms. Hypointesities, like that observed in Figure 4B in vivo, were
also observed in excised lymph nodes imaged at 7T that correlated with
activated B-cell follicles on pathology7. These heterogeneous
features likely contribute to a higher standard deviation of T2 values measured here in
the hilum. Optimal contrast within the cortex and hilum may be desirable for
determining tumor perimeter as a marker of response to neoadjuvant therapy8.
Further, evaluation of the density of lymphatic microvasculature may allow
detection of lymphangiogenesis9, which may be protective in certain cancers10.Conclusion
These methods allow for improved
clinical imaging of lymph node structure without the use of exogenous contrast
agents, using protocols that can be implemented in less than five minutes with
coverage of the entire axilla. Measurement of T1 and T2
relaxation time constants in lymphatic tissue should have relevance for
developing novel MR imaging and angiography techniques with sensitivity to
lymphatic physiology.Acknowledgements
No acknowledgement found.References
1.
Memarsadeghi
M, Riedl C, Kaneider A, et al. Axillary Lymph Node Metastases in Patients with
Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging.
Radiology. 2006;241(2):367-377.
2.
Donahue
MJ, Donahue PC, Rane S, et al. Assessment of lymphatic impairment and
interstitial protein accumulation in patients with breast cancer
treatment-related lymphedema using CEST MRI. Magnetic Resonance in Medicine.
2015;75(1):345-355.
3.
Rane S, Donahue PMC, Towse T, et al. Clinical feasibility of
noninvasive visualization of lymphatic flow with principles of spin labeling MR
imaging: implications for lymphedema assessment. Radiology.
2013;269(3):893-902.
4.
Wang J, Qiu M, Kim H, et al. T1 Measurements incorporating
flip angle calibration and correction in vivo. Journal of Magnetic Resonance.
2006;182(2):283-292.
5.
Zhao JM, Clingman CS, Narvainen MJ, et al. Oxygenation and
hematocrit dependence of transverse relaxation rates of blood at 3T. Magnetic
Resonance in Medicine. 2007;58(3):592-597.
6.
Li W, Grgac K, Huang A, et al. Quantitative theory for the
longitudinal relaxation time of blood water. Magnetic Resonance in Medicine.
2016;76(1):270-281.
7.
Korteweg MA, Zwanenburg JJM, van Diest PJ, et al.
Characterization of ex vivo healthy human axillary lymph nodes with high
resolution 7 Tesla MRI. European Radiology. 2011;21(2):310-317.
8.
Liu
SV, Melstrom L, Yao K, et al. Neoadjuvant therapy for breast cancer. Journal of
Surgical Oncology, 2010;101(4):283-291.
9.
Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in
development and human disease. Nature. 2005;438(7070):946-953.
10.
Fischbein NJ, Noworolski SM, Henry RG, et al. Assessment of
metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging.
American Journal of Neuroradiology. 2003;24(3):301-311.